Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.0055 USD
Change Today 0.00 / 0.00%
Volume 0.0
BGES On Other Exchanges
Symbol
Exchange
OTC US
As of 4:30 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

bio-bridge science inc (BGES) Snapshot

Open
--
Previous Close
$0.0055
Day High
--
Day Low
--
52 Week High
09/11/14 - $0.06
52 Week Low
10/22/14 - $0.0050
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
$-0.03
Shares Outstanding
46.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIO-BRIDGE SCIENCE INC (BGES)

Related News

No related news articles were found.

bio-bridge science inc (BGES) Related Businessweek News

No Related Businessweek News Found

bio-bridge science inc (BGES) Details

Bio-Bridge Science Inc., a biotechnology company, focuses on the commercial development of vaccines for the prevention and treatment of human immunodeficiency virus (HIV) diseases. Its products under development include a HIV vaccine to prevent acquired immunodeficiency syndrome; a colon cancer therapeutic vaccine; HIV-PV vaccine for the prevention of cervical cancer; and mucosal adjuvant products. The company holds license for the HIV vaccine and colon cancer vaccine technology with respect to development and sale in the territories of the People’s Republic of China, Japan, and the United States. It also offers vaccine production-related materials. The company was founded in 2002 and is based in Oak Brook, Illinois.

23 Employees
Last Reported Date: 04/15/11
Founded in 2002

bio-bridge science inc (BGES) Top Compensated Officers

Co-Founder, Chairman and Secretary
Total Annual Compensation: --
Co-Founder and Director
Total Annual Compensation: --
Co-Founder and Director
Total Annual Compensation: --
Principal Financial Officer and Controller
Total Annual Compensation: --
Consultant
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BGES:US $0.01 USD 0.00

BGES Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BGES.
View Industry Companies
 

Industry Analysis

BGES

Industry Average

Valuation BGES Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.3x
Price/Book 0.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-BRIDGE SCIENCE INC, please visit www.bio-bridge-science.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.